SCHEMBL30760073

SCHEMBL30760073

CC(C)(C)OC(=O)N[C@@H](CO)c1ccc(-c2cnccn2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP19A1 P11511 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
AAK1 Q2M2I8 2/20 0.39
CYP17A1 P05093 2/20 0.39
SCN9A Q15858 1/20 0.38
ROCK2 O75116 4/20 0.38
ROCK1 Q13464 3/20 0.38
MAPK1 P28482 2/20 0.38
MAPK13 O15264 1/20 0.38
RPS6KA5 O75582 1/20 0.38
MAP4K4 O95819 1/20 0.38
PAK4 O96013 1/20 0.38
PRKCG P05129 1/20 0.38
CDK1 P06493 1/20 0.38
PRKACA P17612 1/20 0.38
RPS6KB1 P23443 1/20 0.38
CDK2 P24941 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30759993 0.83 DHPS (0.47) AAK1CYP17A1ROCK2ROCK1MAPK1
SCHEMBL30760184 0.82 MAPK1 (0.51) AAK1CYP17A1ROCK2ROCK1MAPK1
SCHEMBL30759979 0.81 AAK1 (0.41) AAK1CYP17A1SCN9AROCK2ROCK1
SCHEMBL30760154 0.81 ROCK2 (0.43) AAK1CYP17A1SCN9AROCK2ROCK1
SCHEMBL30760201 0.81 MAPK1 (0.41) AAK1CYP17A1ROCK2ROCK1MAPK1
SCHEMBL30760070 0.81 ROCK1 (0.44) CYP2C9AAK1CYP17A1SCN9AROCK2
SCHEMBL30760140 0.81 CACNA1I (0.39) AAK1CYP17A1ROCK2ROCK1MAPK1
SCHEMBL31407232 0.80 ROCK2 (0.46) AAK1CYP17A1ROCK2ROCK1MAPK1
SCHEMBL15889687 0.79 MAPK1 (0.41) AAK1MAPK1PTPRB
SCHEMBL30759976 0.79 HDAC4 (0.45) HDAC4AAK1CYP17A1SCN9AROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024040080-A1 KRAS INHIBITOR CONJUGATES ERASCA, INC. (US) 2024-02-22 WO disclosed